A detailed history of Virtus ETF Advisers LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 40,564 shares of CDNA stock, worth $646,590. This represents 0.44% of its overall portfolio holdings.

Number of Shares
40,564
Previous 4,299 843.57%
Holding current value
$646,590
Previous $84,000 601.19%
% of portfolio
0.44%
Previous 0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$11.57 - $20.63 $419,586 - $748,146
36,265 Added 843.57%
40,564 $589,000
Q2 2025

Aug 13, 2025

SELL
$14.18 - $20.08 $514,237 - $728,201
-36,265 Reduced 89.4%
4,299 $84,000
Q1 2025

May 14, 2025

BUY
$17.64 - $25.07 $715,548 - $1.02 Million
40,564 New
40,564 $720,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $852M
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.